<p>Dr Juraj Sykora works at the National Cancer Institution, is an associate editor of EJHP and faculty member for EAHP. Here he discusses EAHP 2014, innovation and biosimilars.</p><p>This podcast is in Slovak, and was recorded at EAHP 2014.</p>

Dr Juraj Sykora works at the National Cancer Institution, is an associate editor of EJHP and faculty member for EAHP. Here he discusses EAHP 2014, innovation and biosimilars. This podcast is in Slovak, and was recorded at EAHP 2014.

EAHP 2014, innovation, and biosimilars (in Slovak)

The European Journal of Hospital Pharmacy: Science and Practice (EJHP) offers a high-quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of European hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy.
It is our goal that the Journal becomes a major source for education and inspiration to improve practice and standard of patient care in hospitals and related institutions.

Medicine

The European Journal of Hospital Pharmacy: Science and Practice (EJHP) offers a high-quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of European hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. It is our goal that the Journal becomes a major source for education and inspiration to improve practice and standard of patient care in hospitals and related institutions.

Share EAHP 2014, innovation, and biosimilars (in Slovak)

Sign up to save your podcasts

EAHP 2014, innovation, and biosimilars (in Slovak)

EAHP 2014, innovation, and biosimilars (in Slovak)